UMR912, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM), Institut National de la Santé et de la Recherche Médicale (INSERM), Marseille, France.
PLoS One. 2012;7(12):e52429. doi: 10.1371/journal.pone.0052429. Epub 2012 Dec 18.
In developed countries, primary care physicians manage most patients with depression. Relatively few studies allow a comprehensive assessment of the decisions these doctors make in these cases and the factors associated with these decisions. We studied how general practitioners (GPs) manage the acute phase of a new episode of non-comorbid major depression (MD) and the factors associated with their decisions.
METHODOLOGY/PRINCIPAL FINDINGS: In this cross-sectional telephone survey, professional investigators interviewed an existing panel of randomly selected GPs (1249/1431, response rate: 87.3%). We used case-vignettes about new MD episodes in 8 versions differing by patient gender and socioeconomic status (blue/white collar) and disease intensity (mild/severe). GPs were randomized to receive one of these 8 versions. Overall, 82.6% chose pharmacotherapy; among them GPs chose either an antidepressant (79.8%) or an anxiolytic/hypnotic alone (18.5%). They rarely recommended referral for psychotherapy alone, regardless of severity, but 38.2% chose it in combination with pharmacotherapy. Antidepressant prescription was associated with severity of depression (OR = 1.74; 95%CI = 1.33-2.27), patient gender (female, OR = 0.75; 95%CI = 0.58-0.98), GP personal characteristics (e.g. history of antidepressant treatment: OR = 2.31; 95%CI = 1.41-3.81) and GP belief that antidepressants are overprescribed in France (OR = 0.63; 95%CI = 0.48-0.82). The combination of antidepressants and psychotherapy was associated with severity of depression (OR = 1.82; 95%CI = 1.31-2.52), patient's white-collar status (OR = 1.58; 95%CI = 1.14-2.18), and GPs' dissatisfaction with cooperation with mental health specialists (OR = 0.63; 95%CI = 0.45-0.89). These choices were not associated with either GPs' professional characteristics or psychiatrist density in the GP's practice areas.
CONCLUSIONS/SIGNIFICANCE: GPs' choices for treating severe MD complied with clinical guidelines better than those for mild MD; GPs rarely recommended psychotherapy alone but rather as a complement to pharmacotherapy. Their decisions were mainly influenced by personal life experience and attitudes regarding treatment more than by professional characteristics. These results call into question the methods and content of continuing medical education in France about MD management.
在发达国家,初级保健医生管理大多数抑郁症患者。相对较少的研究能够全面评估这些医生在这些情况下做出的决策以及与这些决策相关的因素。我们研究了全科医生(GP)如何管理新发非共病重度抑郁症(MD)的急性期以及与这些决策相关的因素。
方法/主要发现:在这项横断面电话调查中,专业研究人员对一个随机选择的 GP 现有小组(1249/1431,响应率:87.3%)进行了访谈。我们使用了 8 种不同版本的新 MD 发作病例描述,这些版本在患者性别和社会经济地位(蓝领/白领)和疾病严重程度(轻度/重度)方面有所不同。GP 随机收到这 8 个版本中的一个。总体而言,82.6%的医生选择药物治疗;其中,79.8%的医生选择抗抑郁药,18.5%的医生选择抗焦虑/催眠药。他们很少推荐仅进行心理治疗,无论严重程度如何,但 38.2%的医生选择将其与药物治疗联合使用。抗抑郁药的处方与抑郁严重程度相关(OR=1.74;95%CI=1.33-2.27),与患者性别相关(女性,OR=0.75;95%CI=0.58-0.98),与 GP 个人特征相关(例如,抗抑郁药治疗史:OR=2.31;95%CI=1.41-3.81),与 GP 认为抗抑郁药在法国开得过多的信念相关(OR=0.63;95%CI=0.48-0.82)。抗抑郁药与心理治疗的联合使用与抑郁严重程度相关(OR=1.82;95%CI=1.31-2.52),与患者的白领身份相关(OR=1.58;95%CI=1.14-2.18),与 GP 对与精神卫生专家合作的不满相关(OR=0.63;95%CI=0.45-0.89)。这些选择与 GP 的专业特征或 GP 执业领域的精神科医生密度无关。
结论/意义:GP 治疗重度 MD 的选择比治疗轻度 MD 的选择更符合临床指南;GP 很少推荐单独进行心理治疗,而是将其作为药物治疗的补充。他们的决策主要受个人生活经历和治疗态度的影响,而不是专业特征的影响。这些结果质疑了法国关于 MD 管理的继续医学教育的方法和内容。